We're seeing rapid revenue growth on very high gross margins (indicating doctors are happy to pay premium prices), sticky customer base, recurring revenue generation, surging production of peer reviewed evidence supporting our procedure... not sure what you're trying to say here mate. The hard numbers, the evidence, all indicate that we've got a product which doctors love and can't get enough of.
Unlike one particular company starting with M which has yet to help a single person or sell a single product, and relies on regularly bleeding shareholders dry to pay its management high salaries until its eventual insolvency and delisting.
PNV - Banter and General Comments, page-10597
-
- There are more pages in this discussion • 1,787 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.58 |
Change
-0.060(2.27%) |
Mkt cap ! $1.788B | |||
| Open | High | Low | Value | Volume |
| $2.63 | $2.64 | $2.57 | $1.297M | 499.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 34 | 46023 | $2.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.59 | 16630 | 34 |
View Market Depth
| Last trade - 15.52pm 30/09/2024 (20 minute delay) ? |
| PNV (ASX) Chart |